The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
High-grade ovarian serous carcinomas (HGSC) are characterized by TP53 mutations and non-random patterns of chromosomal anomalies, where the nature of the TP53 mutation may correlate with clinical outcome. However, the frequency of common somatic genomic events occurring in HGSCs from demographically...
Main Authors: | Paulina M Wojnarowicz, Kathleen Klein Oros, Michael C J Quinn, Suzanna L Arcand, Karen Gambaro, Jason Madore, Ashley H Birch, Manon de Ladurantaye, Kurosh Rahimi, Diane M Provencher, Anne-Marie Mes-Masson, Celia M T Greenwood, Patricia N Tonin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23029043/pdf/?tool=EBI |
Similar Items
-
Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.
by: Ashley H Birch, et al.
Published: (2011-01-01) -
Expression signatures of <it>TP53 </it>mutations in serous ovarian cancers
by: Murphy Susan K, et al.
Published: (2010-05-01) -
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
by: Ahmed, A, et al.
Published: (2010) -
Characterization of three new serous epithelial ovarian cancer cell lines
by: Hébert Josée, et al.
Published: (2008-05-01) -
Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
by: Melania Tesio
Published: (2023-02-01)